(Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the status of ...
RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025.
Opus Genetics and Viatris, Inc. (Viatris) (through its affiliate) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants ...
STAAR Surgical Company , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, today announced that more than 4 million Implantable ...
FDA PDUFA Goal Date Set for October 17, 2026PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today ...
For discussion purposes, our comments on growth rates are expressed in constant currency. Dave will then return with closing ...
D-Wave Quantum Inc. (NYSE: QBTS), (“D-Wave”) a leader in quantum computing systems, software and services, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results